CTXR - Citius Pharmaceuticals, Inc.
0.8351
-0.114 -13.591%
Share volume: 937,385
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.95
-0.11
-0.12%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-14-2024 | 08-12-2024 | 02-14-2025 | 02-14-2025 | 05-14-2025 | 08-12-2025 | 12-23-2025 | 02-13-2026 | |
| Assets | |||||||||
| Total Assets | 90.711 M | 97.091 M | 116.652 M | 120.703 M | 121.481 M | 127.677 M | 130.938 M | 140.392 M | |
| Current Assets | 21.574 M | 28.006 M | 14.221 M | 18.327 M | 18.374 M | 24.611 M | 27.934 M | 37.945 M | |
| Inventories | 0.000 | 0.000 | 8.515 M | 14.573 M | 15.339 M | 17.209 M | 22.287 M | 22.639 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 12.560 M | 17.911 M | 3.252 M | 1.100 M | 26.410 K | 6.089 M | 4.252 M | 7.721 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 275.000 | 0.000 | 0.000 | 0.000 | 922.099 K | 0.000 | 818.694 K | 835.177 K | |
| Other Assets | 69.137 M | 69.085 M | 102.185 M | 102.185 M | 102.185 M | 205.250 M | 204.370 M | 101.611 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 90.711 M | 97.091 M | 116.652 M | 120.703 M | 121.481 M | 127.677 M | 130.938 M | 140.392 M | |
| Total liabilities | 10.744 M | 10.806 M | 42.550 M | 51.784 M | 57.906 M | 60.116 M | 53.410 M | 46.924 M | |
| Total current liabilities | 4.174 M | 4.152 M | 35.815 M | 44.806 M | 49.877 M | 51.842 M | 44.915 M | 38.207 M | |
| Accounts Payable | 2.670 M | 1.663 M | 4.927 M | 7.364 M | 9.368 M | 10.094 M | 13.694 M | 11.021 M | |
| Other liabilities | 145.098 K | 84.430 K | 21.318 K | 0.000 | 0.000 | 766.957 K | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 145.098 K | 84.430 K | 21.318 K | 0.000 | 0.000 | 766.957 K | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 79.367 M | 85.684 M | 70.077 M | 65.408 M | 60.659 M | 65.059 M | 67.550 M | 79.958 M | |
| Common stock | 259.373 M | 276.264 M | 271.448 M | 276.547 M | 282.714 M | 295.903 M | 306.354 M | 326.983 M | |
| Retained earnings | -180.007 M | -190.580 M | -201.370 M | -211.138 M | -222.055 M | -230.845 M | -238.804 M | -247.025 M |